- Home
- YI vs BRNS Comparison
YI vs BRNS Comparison
Compare YI & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YI
- BRNS
- Stock Information
- Founded
- YI 2010
- BRNS 2016
- Country
- YI China
- BRNS United Kingdom
- Employees
- YI N/A
- BRNS N/A
- Industry
- YI Retail-Drug Stores and Proprietary Stores
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- YI Consumer Staples
- BRNS Health Care
- Exchange
- YI Nasdaq
- BRNS Nasdaq
- Market Cap
- YI 64.4M
- BRNS 52.0M
- IPO Year
- YI N/A
- BRNS 2021
- Fundamental
- Price
- YI $0.63
- BRNS $0.97
- Analyst Decision
- YI
- BRNS Strong Buy
- Analyst Count
- YI 0
- BRNS 2
- Target Price
- YI N/A
- BRNS $4.00
- AVG Volume (30 Days)
- YI 111.3K
- BRNS 31.7K
- Earning Date
- YI 11-27-2024
- BRNS 11-06-2024
- Dividend Yield
- YI N/A
- BRNS N/A
- EPS Growth
- YI N/A
- BRNS N/A
- EPS
- YI N/A
- BRNS N/A
- Revenue
- YI $2,026,540,888.00
- BRNS $14,969,000.00
- Revenue This Year
- YI $61.85
- BRNS N/A
- Revenue Next Year
- YI N/A
- BRNS N/A
- P/E Ratio
- YI N/A
- BRNS N/A
- Revenue Growth
- YI 0.38
- BRNS 106.21
- 52 Week Low
- YI $0.55
- BRNS $0.88
- 52 Week High
- YI $2.34
- BRNS $4.16
- Technical
- Relative Strength Index (RSI)
- YI 37.59
- BRNS 30.37
- Support Level
- YI $0.65
- BRNS $1.28
- Resistance Level
- YI $0.70
- BRNS $1.52
- Average True Range (ATR)
- YI 0.05
- BRNS 0.13
- MACD
- YI -0.01
- BRNS -0.04
- Stochastic Oscillator
- YI 11.59
- BRNS 14.09
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.